Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission. - Wikidata - wikimedia - TriplyDB

Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.

Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.

http://www.wikidata.org/entity/Q34979564

about

FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML Incorporating measurable ('minimal') residual disease-directed treatment strategies to optimize outcomes in adults with acute myeloid leukemia.Total Body Irradiation without Chemotherapy as Conditioning for an Allogeneic Hematopoietic Cell Transplantation for Adult Acute Myeloid Leukemia.Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

P2860

Q36484100-951CBF49-230B-4CC5-A901-086171E95152 Q37141503-2FDCD2CC-2AB8-45E2-957D-A86793FC7DE9 Q37443163-2C707E58-A08F-4335-93F6-35FB30FE1479 Q48568744-418F0425-58F3-421D-9933-1E70A7AE2CF7

P2860

Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.

http://www.wikidata.org/entity/Q34979564

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Number of courses of induction ...... first morphological remission.

@ast

Number of courses of induction ...... first morphological remission.

@en

Number of courses of induction ...... first morphological remission.

@nl

type

label

Number of courses of induction ...... first morphological remission.

@ast

Number of courses of induction ...... first morphological remission.

@en

Number of courses of induction ...... first morphological remission.

@nl

prefLabel

Number of courses of induction ...... first morphological remission.

@ast

Number of courses of induction ...... first morphological remission.

@en

Number of courses of induction ...... first morphological remission.

@nl

P1433

Q34979564-DC6D646A-5C6A-4306-9B5A-28CF59FE47AC

P1476

Q34979564-2118A950-60FF-4233-BFC5-414D9DBBB573

P2093

Q34979564-076FCEC3-5D65-48EA-A72D-1EF3463488B1

Q34979564-27E36B7D-AB63-4F52-B006-7730A16BD5CF

Q34979564-86F572F2-5D5F-4DF3-A46C-61C433A08936

Q34979564-EBF18154-DEC8-4E07-BB5E-329CAB87929C

Q34979564-F7E2663B-A1E1-42CF-A931-019E9BF72F9E

P2860

Q34979564-1E177866-E6BC-4EE4-9FEC-B194D547003C

Q34979564-2FE6E9E6-3316-4E18-A120-FE8D2B7E897F

Q34979564-35EE0682-A7F8-4DE7-95CE-2E976E1FF595

Q34979564-367D041A-C043-48B0-A11B-073014216F0C

Q34979564-3B248A12-9B26-4C67-B0DC-E25B2AA18776

Q34979564-438858B1-8AB1-45EA-8F21-CC29FA31CA25

Q34979564-4E2EE734-4572-435E-995A-DD925FBE328D

Q34979564-4E4A7972-97A3-4692-9156-2432B7AC6C65

Q34979564-5F5B3571-DE73-4C51-A9B0-72E2C61BBC90

Q34979564-66739B32-A5AB-4422-8110-437603F76B48

P304

Q34979564-70DD041A-D4D6-421E-B0FB-BD6CCC452A54

P31

Q34979564-45F3C019-A9A6-45AA-A048-69DEBF97C02F

P356

Q34979564-8CE12723-A454-4089-B814-9C6B4FA52069

P433

Q34979564-84D9F1CA-08FF-42A6-AF71-0048E8ADD930

P478

Q34979564-9DE113FC-93A8-4A02-ACCE-49D80FC991C2

P50

Q34979564-32C7C68F-FEE4-4B63-BDE2-F4078076352E

Q34979564-4F39C7CD-91DA-4695-882B-0EEA90628542

Q34979564-70739CFC-F29D-4387-882B-5115D8085199

Q34979564-AD5250A6-3841-468D-8E81-D3C96FBFE031

Q34979564-C21EE641-EBC8-403D-8617-E3BE52D467B1

P577

Q34979564-D63CE6E1-DA8B-4151-9417-E5A247193792

P698

Q34979564-C80C5F33-518B-4167-96AE-0FD468B54F67

P921

Q34979564-0BFF74D2-BF5A-43B8-BE80-DC26551D0A8E

P932

Q34979564-29E5A8E3-239E-4C3B-AFBD-984FB826CB61

P356

J.BBMT.2014.09.022

P1433

Biology of Blood and Marrow Transplantation

P1476

Number of courses of induction ...... first morphological remission.

@en

P2093

Colin D Godwin

http://www.w3.org/2001/XMLSchema#string

John M Pagel

http://www.w3.org/2001/XMLSchema#string

Mohamed L Sorror

http://www.w3.org/2001/XMLSchema#string

Roland B Walter

http://www.w3.org/2001/XMLSchema#string

Sarah A Buckley

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Part

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial.

Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation.

Minimal residual disease in acute myeloid leukaemia

Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.

P304

373-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2014.09.022

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Rainer F. Storb

Brenda M Sandmaier

Frederick R. Appelbaum

Hans Joachim Deeg

P577

2014-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25278455

http://www.w3.org/2001/XMLSchema#string

P921

P932

4297535

http://www.w3.org/2001/XMLSchema#string